Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||-5.63%||7.55||0.7%||$527.77m|
|REGN||Regeneron Pharmaceuticals, Inc.||-0.58%||499.69||2.7%||$447.00m|
|GILD||Gilead Sciences, Inc.||-1.38%||65.95||1.0%||$437.06m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.10%||219.18||1.9%||$383.57m|
|ALXN||Alexion Pharmaceuticals, Inc.||1.09%||165.47||2.0%||$360.29m|
|NBIX||Neurocrine Biosciences, Inc.||-1.79%||94.85||4.9%||$180.78m|
|EXAS||EXACT Sciences Corp.||-1.93%||127.53||18.4%||$168.47m|
|CRSP||CRISPR Therapeutics AG||-2.97%||115.04||0.6%||$158.56m|
AIkido Pharma, Inc. is a biotechnology development company, which engages in the provision of diversified portfolio of small-molecule anticancer and antiviral therapeutics in development. Its oncology therapeutics includes treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It also creates broad-spectrum antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.